Roots Analysis

DECEMBER 11, 2022

Antibody drug conjugates (ADCs) are an upcoming class of targeted therapeutic agents that have garnered the attention of pharmaceutical companies, and academic / research institutions across the world. What are the key trends that are shaping up the ADC contract manufacturing market?

Antibody 40

Antibody Marketing Contract Manufacturing Drugs 40

Roots Analysis

FEBRUARY 15, 2022

Over time, medical researchers have been able to further develop their understanding of the intricacies of ADC design and have also improved the development process of these complex pharmacological interventions. As per the estimates, 70-80% of ADC manufacturing operations are outsourced. Rise in Intellectual Property Portfolio.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing Containment 52

The Pharma Data

SEPTEMBER 11, 2021

Senior Corporate Vice President and Global Head of Discovery Research at Boehringer Ingelheim. “We Twist and Boehringer Ingelheim will work together to validate and optimize any resulting new antibody candidates, which could be researched against a range of therapeutic areas. This press release contains forward-looking statements.

Antibody 52

Antibody DNA Containment Manufacturing 52

Roots Analysis

AUGUST 29, 2024

These kits contain a sterilized vial filled with non-radionuclide component (carrier molecule) to which an appropriate radionuclide is added / diluted for the purpose of diagnostics, therapeutics and theranostics. Notably, close to 50% of these non-industry players are engaged in contract manufacturing of radiopharmaceuticals.

Production 52

Production Marketing Manufacturing Contract Manufacturing 52

Roots Analysis

OCTOBER 24, 2023

Owing to the advancement in clinical pharmacology and oncology domain, and the rising demand for targeted therapeutics and precision medicines, high potency active pharmaceutical ingredients (HPAPIs) and cytotoxic drugs have become one of the key areas of interest to researchers and drug manufacturers across the globe.

Manufacturing 40

Manufacturing Hormones Contamination Containment 40

XTalks

FEBRUARY 11, 2021

The RNA is transcribed from DNA in 40-liter vessels containing enzymes and chemicals over the course of three to four days. Given RNA’s instability and high susceptibility to degradation (due to RNAses from other organisms and those lurking in the general environment), the RNA is produced in an extremely high-tech manufacturing suite.

Manufacturing 52

Manufacturing Vaccination Vaccine DNA 52

The Pharma Data

JANUARY 5, 2021

based contract manufacturing business, Benuvia Manufacturing, which has significant chemistry and formulation capabilities, including manufacturing our FDA-approved cannabinoid drug, SYNDROS ® ,” said Todd C. We look forward to supporting Radius through our U.S. Theresa Strong, Ph.D., ” Clinical Highlights.

Manufacturing 52

Manufacturing FDA Approval Trials Development 52

The Pharma Data

JANUARY 27, 2021

. “The addition of scalable in-house manufacturing capability creates the potential for significant growth across virtually all of our development and commercialization programs.” ” Vektor is a German narcotics manufacturer, developer, and researcher located in the district of Biberach, Baden-Württemberg, Germany.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

The Pharma Data

JANUARY 24, 2021

TSXV: THRM) (“Therma Bright” or the “Company”), a progressive medical device technology company announces that it has taken 100% control of the research and development, regulatory, manufacturing and commercialization of its saliva-based rapid antigen test. . – January 25, 2021) – Therma Bright Inc.

Sales 40

Sales Manufacturing Contract Manufacturing Containment 40

The Pharma Data

JULY 21, 2021

The information contained in this release is as of July 21, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. Pfizer Disclosure Notice. For more information, please visit www.BioNTech.de.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

Pharmaceutical Technology

APRIL 24, 2023

“Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

The Pharma Data

DECEMBER 23, 2020

INOVIO is also assessing nonclinical efficacy of INO-4800 in several animal challenge models with Public Health England (PHE) and Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia.

DNA 40

DNA Vaccination Vaccine Immune Response 40

Roots Analysis

JANUARY 15, 2024

Although biopharmaceuticals offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. Advanced and complex technologies are required for manufacturing, as well as testing of biopharmaceuticals.

Contract Manufacturing 40

Contract Manufacturing Manufacturing Production Development 40

Roots Analysis

AUGUST 16, 2023

Given such technical and operational challenges associated with the production of RNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the contract manufacturing service providers to cater to the urgent global demand.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing RNA 52

Pfizer

JANUARY 17, 2023

Upon completion of the construction, the state-of-the-art facility will have extensive capabilities for producing biologics drug substance and provides additional manufacturing capacity allowing Pfizer to help accelerate its innovative pipeline. The information contained in this press release is as of January 17, 2023.

Manufacturing 85

Manufacturing Containment Development Medicine 85

Pharmaceutical Technology

JANUARY 12, 2023

Research Associate III, who is a parenteral fill/finish and lyophilization specialist at Baxter BioPharma Solutions (BPS) – a business unit of Baxter Healthcare, Inc. KB: Some formulations contain low concentrations of the active ingredient. Why is continuing research so important? United Kingdom. United States.

Production 130

Production Contamination Development Manufacturing 130

FDA Law Blog

JANUARY 1, 2024

The letter also stated that the company’s response to the inspection report was “inadequate because it did not include a review of environmental monitoring data in your manufacturing areas, an adequate risk analysis of previously manufactured drug product, or testing of reserve samples from impacted batches.” Dextrum Laboratories Inc.

Manufacturing 59

Manufacturing Production Drugs Contract Manufacturing 59

The Pharma Data

JANUARY 5, 2021

“ This press release contains forward-looking statements about the future development of the Sartorius Group. The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry.

Life Science 40

Life Science Manufacturing Sales Contract Manufacturing 40

The Pharma Data

NOVEMBER 5, 2020

This trial, which is being coordinated by researchers at the University of Oxford , is in patients hospitalized with COVID-19 and will compare the effects of adding REGN-COV2 to the usual standard-of-care versus standard-of-care on its own. Research and development (R&D). $. Cost of goods sold (COGS). $. 30%. *. *.

Sales 40

Sales Production Manufacturing Antibody 40

The Pharma Data

AUGUST 7, 2020

to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Pfizer Disclosure Notice: The information contained in this release is as of August 7, 2020.

Manufacturing 52

Manufacturing Containment Contract Manufacturing Development 52

Roots Analysis

FEBRUARY 13, 2023

As a result, there is an evident increase in the demand for mRNA manufacturing capacity. Application of Synthetic mRNA Several studies conducted by healthcare companies and research institutions have demonstrated the potential of mRNA.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

The Pharma Data

JUNE 24, 2021

The production capacity has consistently grown due to continued enhancements to the vaccine’s supply chain, which include expanding existing facilities, adding more suppliers, and bringing on additional Pfizer/BioNTech sites and contract manufacturers around the world to produce the vaccine. with distinct legal restrictions.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

The Pharma Data

MAY 4, 2021

billion, primarily driven by Pfizer CentreOne, Pfizer’s contract manufacturing operation, reflecting sales of legacy Upjohn products to Viatris (4) and remdesivir to Gilead Sciences Inc., Clinical and Research Developments. Current 2021 financial guidance is presented below. . . down 7%, which reflects relatively stable U.S.

Vaccination 40

Vaccination Vaccine Production Sales 40